The Hamilton Spectator9 天
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
(Anteris® or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart ... at Sydney Valves on Friday 21 March 2025, 10:30am (AEST), titled: “Pioneering a New Class of Biomimetic TAVR ...
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
DurAVR ® THV demonstrated a favorable hemodynamic profile sustained to one-year, with an Effective Orifice Area (EOA) of 2.1 + 0.2 cm 2, a Mean Pressure Gradient (MPG) of 8.6 + 2.6 mmHg and Doppler ...